Qana
  • Home
  • landing
    • news
  • Company news
Select Page

Rutledge Cancer Foundation invests in Qana Therapeutics’s Ewing sarcoma program

by admin | May 25, 2023 | Company news

Collaborative preclinical study with Dr. Jason Yustein of Emory University funded by the Rutledge Cancer Foundation. FT WORTH, TEXAS, May 5, 2023,    —  Rutledge Cancer Foundation (RCF) granted $100,000 to Jason Yustein’s lab at Emory University. Yustein and his...

Recent Posts

  • Qana Leadership Travels to Boston for I-Corps Kickoff
  • Qana presents at San Antonio’s BioFest Invest 2024
  • Qana Therapeutics receives NIH (NCI) Innovative Concept Award to advance a novel therapeutic for adrenocortical carcinoma
  • Qana closes new funding from leading mid-continent seed stage investor
  • Rutledge Cancer Foundation invests in Qana Therapeutics’s Ewing sarcoma program

Recent Comments

    Archives

    • July 2024
    • April 2024
    • August 2023
    • May 2023

    Categories

    • Company news

    Team

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © Copyright 2025. Qana Therapeutics Inc. All Rights Reserved.